- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2006
- Public Summary Document (PSD) July 2006 PBAC Meeting - PDF
Posaconazole – July 2006
Posaconazole, oral suspension, 40 mg per mL, 105 mL, Noxafil®, July 2006
Last updated
27 October 2006